Technology Networks
Webcasts
Latest Webcasts

Enabling Personalised Medicine From FFPE Tissue

Austin Tanney, Scientific Liaison Manager, Almac

Date Posted: Wednesday, January 27, 2010

Print Email to a friend

Launch presentation

Abstract

Molecular profiling and molecular diagnostics are the key to development of the prognostic and predictive tests which will usher in the era of personalised medicine. The development of such tests is often hampered by the lack of suitable tissue samples. Profiling of DNA and RNA from routinely stored formallin fixed and paraffin embedded (FFPE) tissue samples has proved to be hugely challenging. This talk provides an overview of some of the issues surrounding working with FFPE samples and how these can now be addressed. Examples will be given showing the application of RNA profiling in biomarker discovery from FFPE tissue.

Launch presentation



Related Products

Almac Diagnostics Launches Ovarian Cancer Research Tool
The Cancer DSA™ research tool has additional disease specific information which is optimized for use with FFPE tissue.



Related news from our archive

Bioinformatics Expansion Heralds Further Growth for Almac
Almac Diagnostics – a personalized medicine company today announced the extension of its Bioinformatics department.

Gene Expression Study to Develop Prognostic Test for Early Non-Small Cell Lung Cancer
Almac Diagnostics has announced details of a global multi-centre collaborative lung cancer study with leading research organisations in the USA, Canada, Asia and Europe.

Almac Signs Deal to Provide Process to Extract Genetic Information from Clinical Trial Samples
Newly validated capability developed by Almac to be used by Biogen Idec in gastrointestinal cancer study.